Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 36INDUSTRY 9NETWORK 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 6Gynecologic 1

Conditions

Hydatidiform Mole 1Gestational Trophoblastic Disease 1

Interventions

Cisplatin 9apatinib 5Surgical Procedures, Operative 4Radiotherapy 4Paclitaxel 4Hyperthermic Intraperitoneal Chemotherapy 4Hydralazine 4Gemcitabine 4Carboplatin 4Valproic Acid 3Neoadjuvant Therapy 3Drug Therapy 3Bevacizumab 3taxane 2pembrolizumab 2cetrorelix 2Radiotherapy, Intensity-Modulated 2Probiotics 2Population Groups 2Poly(ADP-ribose) Polymerase Inhibitors 2Metformin 2Laparoscopy 2Indocyanine Green 2Etoposide 2Curcumin 2CP protocol 2Brachytherapy 2spartalizumab 1piperine 1olaparib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Letrozole × Gynecologic × Clear all
NCT05203562 2022-07-12

Letrozole as a Prophylaxis From GTN for Complete Mole Patients

Zagazig University

Phase 2/3 Unknown
200 enrolled
Gynecologic

Hydatidiform Mole, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡